Reuters logo
BRIEF-IntelGenx announces decisions in Suboxone(R) patent litigation
September 6, 2017 / 12:09 PM / 2 months ago

BRIEF-IntelGenx announces decisions in Suboxone(R) patent litigation

Sept 6 (Reuters) - IntelGenx Technologies Corp

* IntelGenx announces decisions in Suboxone(R) patent litigation

* IntelGenx- U.S. court said process to make buprenorphine/naloxone sublingual film product for treatment of opiate addiction does not infringe MonoSol Rx patent

* IntelGenx - Court rendered decision in separate case, denying IntelGenx’ and Par’s motion to reopen case Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below